| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |